0001477449-24-000147.txt : 20240604
0001477449-24-000147.hdr.sgml : 20240604
20240604160537
ACCESSION NUMBER: 0001477449-24-000147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240531
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cave James L.
CENTRAL INDEX KEY: 0002019394
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 241017934
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
wk-form4_1717531528.xml
FORM 4
X0508
4
2024-05-31
0
0001477449
Teladoc Health, Inc.
TDOC
0002019394
Cave James L.
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
INTERIM CAO
0
Common Stock
2024-05-31
4
M
0
339
A
10787
D
Common Stock
2024-05-31
4
M
0
1001
A
11788
D
Common Stock
2024-05-31
4
M
0
383
A
12171
D
Common Stock
2024-05-31
4
M
0
1162
A
13333
D
Common Stock
2024-06-03
4
S
0
854
11.157
D
12479
D
Restricted Stock Units
2024-05-31
4
M
0
339
0
D
Common Stock
339
1017
D
Restricted Stock Units
2024-05-31
4
M
0
1001
0
D
Common Stock
1001
0
D
Restricted Stock Units
2024-05-31
4
M
0
383
0
D
Common Stock
383
1534
D
Restricted Stock Units
2024-05-31
4
M
0
1162
0
D
Common Stock
1162
8139
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date.
On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2024-06-04